Shareholders | Shares | Votes (%) |
|---|---|---|
Total | 597 287 105 | 100,0 |
AILEEN JANE MCGETTRICK | 31 505 100 | 5,27 |
PAUL BRENDAN MONAGHAN | 31 505 100 | 5,27 |
JULIE RICHARDS | 31 505 100 | 5,27 |
STEVEN ANDREW ROSS | 31 505 100 | 5,27 |
FÖRSÄKRINGSAKTIEBOLAGET AVANZA PENSION | 23 224 859 | 3,89 |
NORDIC UNDERWRITING APS | 16 668 382 | 2,79 |
THE BANK OF NEW YORK MELLON, W9* | 11 253 728 | 1,88 |
CARDEON AB (PUBL) | 9 350 000 | 1,57 |
HANDELSBANKEN LIVFÖRSÄKRINGSAKTIEBOLAG | 5 010 523 | 0,84 |
TUVEDALEN LIMITED | 4 792 356 | 0,80 |
Total, 10 largest owners | 196 320 248 | 32,87 |
Other owners | 400 966 857 | 67,13 |
* Refers to the technology and development partner’s ownership (TTP, via management structure).
The company has outstanding warrants for management and board of 2,500,000 and employees of Psyros Diagnostics Ltd. of 5,370,000, which can result in a total of
7,870,000 shares and can thus cause dilution. As of January 2024, the company has outstanding warrants series TO7 of 108,756,747 options.
Prolight Diagnostics’ share is traded on the Nordic Growth Market, NGM SME, under the name PRLD.
Source: Euroclear
